Bradley Pharmaceuticals Inc

Bradley Pharmaceuticals — Merger or Acquisition (December 2007)

16 slides from Bradley Pharmaceuticals's merger presentation, Dec 5, 2007

  1. Slide 1: Integration Planning Team Kick-Off Meeting

    Exhibit 99.2 Integration Planning Team Kick-Off Meeting November 27, 2007

  2. Slide 2: Who is Nycomed?

    Who is Nycomed? Nycomed Worldwide Headquarters in Zurich Nycomed US Headquarters in Melville, NY Nycomed Worldwide: Nycomed US: Nycomed is a privately owned Nycomed US Inc. (formerly Altana Inc) is a pharmaceutical company that provides subsidiary of Nycomed, which operates medicines for hospitals,

  3. Slide 3: Nycomed US, Inc. – Snapshot

    Nycomed US, Inc. – Snapshot A FULLY INTEGRATED US BASED SUBSIDIARY OF NYCOMED History Sales and Sales Operations National Accounts: Retail, Wholesale, Institutional From a small pharmacy in downtown Dermatology Sales Force – 60 sales representatives Brooklyn in 1849, Edmond Fougera of Chaillon, Fran

  4. Slide 4: We have over 158 Years of Experience in the US Pharmaceuticals Market

    We have over 158 Years of Experience in the US Pharmaceuticals Market E. Fougera & Co. Service to pharmacy since 1849 From a small pharmacy in downtown Brooklyn in 1849, Edmond Fougera of Chaillon, France, began a business that would survive and thrives to this day. Initially both manufacturing and

  5. Slide 5: We are the leading Manufacturer of Topical Rx Products for the US

    We are the leading Manufacturer of Topical Rx Products for the US (made in the USA) Headquarters Production/Labs in Melville, NY Main Production Facility in Hicksville, NY

  6. Slide 6: We distribute over 60 million units (SKUs) each year from our Distribution Centers

    We distribute over 60 million units (SKUs) each year from our Distribution Centers Mechanicsburg, PA Tolleson, AZ A 2006 addition of 61,000 square feet brings the New 56,000 square foot DC center opened 2003 total operating area to over 137,000 square feet Equipped with advanced fiber optic Equipped

  7. Slide 7: We are the Leader in Topical Rx Product Research and Development

    We are the Leader in Topical Rx Product Research and Development Nycomed US Approvals vs Competitors 14 12 Nycomed 10 Taro 8 Perrigo 6 Total Approvals: 4 Nycomed US – 56 2 Taro – 35 0 Perrigo – 23 2000 2001 2002 2003 2004 2005 2006 Current Product Development Stage Clinical ANDA/ New Product Product

  8. Slide 8: We are the most successful Rx Topical Specialty Manufacturer in the US

    We are the most successful Rx Topical Specialty Manufacturer in the US Experts in Topical Product Development: We have successfully developed more topical prescription products for the US market from our labs here in NY than anyone in the world. Experts in low-cost topical Rx product manufacturing:

  9. Slide 9: Our Vision is to leverage this success into a leadership position in Dermatology

    Our Vision is to leverage this success into a leadership position in Dermatology Vision Statement Our vision is to become a worldwide leader in the development, manufacturing and commercialization of Dermatology products Strategy Leverage internal core competencies and pursue strategic business deve

  10. Slide 10: Nycomed US Divisions

    Nycomed US Divisions Fougera Number 1 supplier of topical Rx and Non-Rx preparations for Net Sales by Division dermatologic and ophthalmic ointment applications 1 Number of Product Groups in 2006: 44 PharmaDerm Number of SKUs in 2006: 267 19% Hospital 23% Hospital/Emergency Medicine Hospital based e

  11. Slide 11: Fougera Division

    Fougera Division Fougera Number 1 supplier of topical Rx and Non-Rx preparations for dermatologic and ophthalmic ointment applications 1 Number of Product Groups in 2006: 44 Number of SKUs in 2006: 267 Net Sales (2004-2007) Net Sales ($M) 180 160 140 120 100 80 163 171 157 135 60 40 20 0 2004 2005 2

  12. Slide 12: Hospital/Emergency Medicine Division

    Hospital/Emergency Medicine Division Emergency Medicine Hospital based emergency medical products including CroFab (anti-venom), and DigiFab (anti-toxicity) Number of Product Groups in 2006: 4 Number of SKUs in 2006: 7 Net Sales (2004-2007) ($M) 80 70 60 50 40 71 30 63 53 20 44 10 0 2004 2005 2006 2

  13. Slide 13: PharmaDerm Division

    PharmaDerm Division Net Sales (2004-2007) Net Sales ($M) 70 2004-2006 60 Net Sales CAGR2 130% 50 117% Gross Profit CAGR2 40 65 30 20 37 10 21 7 0 2004 2005 2006 2007 PharmaDerm Branded dermatological products, including Cutivate, Oxistat, ApexiCon, Temovate, Aclovate, and ClindaMax Number of Product

  14. Slide 14: Nycomed and Bradley - The Perfect Combination of Strengths

    Nycomed and Bradley - The Perfect Combination of Strengths Core Strengths Required Capabilities for a Leading Specialty Nycomed Pharmaceutical Company US Bradley Target / Lead Identification Business Development Research & Safety Testing (ADME/Tox, pK studies) Discovery Chemical Analysis and Biostat

  15. Slide 15: Together, we will create the preferred Specialty Pharmaceutical Company

    Together, we will create the preferred Specialty Pharmaceutical Company, with a top tier Dermatology Franchise.

  16. Slide 16: Thank you

    Thank you Nycomed P.O. Box 2006 60 Baylis Road Melville, NY 11747 T 631-454-6996 F 631-454-1572 www.nycomed.com [email protected]

Bradley Pharmaceuticals — Merger or Acquisition (December 2007) on 6ix